Penn Medicine's Abramson Cancer Center offers one of the only dedicated neuroendocrine tumor (NET) programs in the country — and is proud to be one of the top neuroendocrine cancer treatment centers in the Mid-Atlantic region.
Our Team of Top NETs Specialists
This strong multidisciplinary program is unique in its combined expertise to treat both gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and pheochromocytomas/paragangliomas (PHEOs). The neuroendocrine-specific tumor board meets every other week, with representation from surgery, gastroenterology, nuclear medicine, medical oncology, radiation oncology and interventional radiology. Each member of our team has great expertise in caring for patients with neuroendocrine tumors.
Neuroendocrine Tumor Clinical Trials and Research
We offer a range of clinical trials for qualified patients. Our neuroendocrine tumor researchers study and save neuroendocrine tumor tissues in their work to develop new treatments for neuroendocrine cancer.
Learn more about clinical trials at Penn